口袋女优

"Nodal radiotherapy for breast cancer no longer needs 5 weeks," researcher says

Survival similar to resection with less morbidity, but editorial suggests use in select patients

A study's 30-year follow-up data provided no new insights into which patients benefit from RT

Fourfold improvement in median PFS when added to standard-of-care systemic therapy

High success rate, few adverse events in patients ineligible for initial trials

A third of patients who had received multiple prior lines of therapy responded, small study shows

Clinical landscape has shifted away from traditional risks for H&N cancer to HPV predominance

No loss in visual acuity, with reduced cost of treatment

All but four of 24 patients had complete responses to 4 Gy, local control rate of 96% at 3 years

EGFR testing now needed for all patients with stage III disease, experts say

Or does it? Editorial questions prognostic, predictive value in contemporary practice

Risk for any second malignancy, death from any second malignancy not higher versus prostatectomy

A Q&A with a physician who got a taste of Hollywood

No difference in freedom from distant metastasis or overall survival at 10 years